Since BCR (BCR-ABL1) and Akt are cell signaling molecules critical for the proliferation of CML cells [22], our finding provides a molecular basis for the involvement of AQP5 in the progression of CML. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.